Kodiak Sciences unveils 7-year performance stock option plan tied to share price milestones up to $800

Kodiak Sciences Inc.

NEOs and eligible employees may forgo up to 75% of annual equity awards for 7 years in exchange for one-time performance stock options.
Options vest in tranches upon achieving stock price milestones: $200/share first, then $100 increments up to $800 (≈$50B market cap).
Operational milestones include FDA approval of KSI-301 in wet AMD, DME, RVO and fiscal-year sales >$2.5B.
90% of eligible employees opted in; awards conditional on stockholder approval at special meeting in October 2021.
Participants are economically worse-off below $400/share compared to continuing annual awards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.